• Tue news: Where do Harris and Trump stand on health policy? Medtronic renal denervation coverage. Canada less likely to have drug shortages? Wall Street wants CVS execution plan. Nektar manufacturing facility sale. See more on our front page

Merck is dead

Quote

Anonymous

Guest
Either you get it or you don't. In a falling industry, Merck is the leading loser.

Have we introduced even one Merck-grown successful product since Fosamax? No. Not even one. It's no wonder we're dying a not-so-slow death.

Look around...half of the reps are gone. In the next year, half of the remaining will be, too.

And there are still some complete Merckoids who believe what management tells them. What a stupid bunch.
 






Anonymous said:
Either you get it or you don't. In a falling industry, Merck is the leading loser.

Have we introduced even one Merck-grown successful product since Fosamax? No. Not even one. It's no wonder we're dying a not-so-slow death.

Look around...half of the reps are gone. In the next year, half of the remaining will be, too.

And there are still some complete Merckoids who believe what management tells them. What a stupid bunch.
Click to expand...

when do you think the layoffs will hit the people beyond the sales?
 




Depends. Whitehouse Station will be the last to go. Manufacturing and its pool of associated jobs will shrink a lot within 5 years. R&D will shrink slightly over the next 2 years and then shrink a lot more as Merck struggles to keep margins. They'll get the numbers by cutting short-term costs at the expense of long term opportunities. Admin and international commercialization/externalization, including joint ventures, will grow. Company thinks that any serious work ought to be done in India and China. Only the incomparable brilliance of Wharton management is impossible to outsource to Asia.

Merck will blink out as Merck within 10 years. It will become just a name for a place that nobody who might have joined 40 years before would possibly recognize. A holding company for talkers.
 




Anonymous said:
Depends. Whitehouse Station will be the last to go. Manufacturing and its pool of associated jobs will shrink a lot within 5 years. R&D will shrink slightly over the next 2 years and then shrink a lot more as Merck struggles to keep margins. They'll get the numbers by cutting short-term costs at the expense of long term opportunities. Admin and international commercialization/externalization, including joint ventures, will grow. Company thinks that any serious work ought to be done in India and China. Only the incomparable brilliance of Wharton management is impossible to outsource to Asia.

Merck will blink out as Merck within 10 years. It will become just a name for a place that nobody who might have joined 40 years before would possibly recognize. A holding company for talkers.
Click to expand...
Your last line is brilliant!! "A HOLDING COMPANY FOR TALKERS." That is so true already...talkers, fakers, fabricators, politicians, snake oilers, gladhandlers, grifters....

I don't understand why the sales reps never leave...one day you wake up and you are over 50 and screwed...get out while you can...go back to school...buy a franchise...do something!! but don't wait around for Merck to get better.
 




Anonymous said:
Either you get it or you don't. In a falling industry, Merck is the leading loser.

Have we introduced even one Merck-grown successful product since Fosamax? No. Not even one. It's no wonder we're dying a not-so-slow death.

Look around...half of the reps are gone. In the next year, half of the remaining will be, too.

And there are still some complete Merckoids who believe what management tells them. What a stupid bunch.
Click to expand...

WTF troll - ever hear of Januvia / Janumet?
 












Anonymous said:
Depends. Whitehouse Station will be the last to go. Manufacturing and its pool of associated jobs will shrink a lot within 5 years. R&D will shrink slightly over the next 2 years and then shrink a lot more as Merck struggles to keep margins. They'll get the numbers by cutting short-term costs at the expense of long term opportunities. Admin and international commercialization/externalization, including joint ventures, will grow. Company thinks that any serious work ought to be done in India and China. Only the incomparable brilliance of Wharton management is impossible to outsource to Asia.

Merck will blink out as Merck within 10 years. It will become just a name for a place that nobody who might have joined 40 years before would possibly recognize. A holding company for talkers.
Click to expand...

Right now there are enough graduates from the Wharton MBA program back in China working to staff the entire Whitehouse Station. The last time I counted we had Wharton MBAs, Harvard MBAs, Columbia MBAs and more working at the HQ and why we are not getting any better?
 








Anonymous said:
Your moron is in your bathroom mirror every morning. Januvia was licensed. Merck just brought it to market. The OP asked for a home-grown product. Januvia isn't one.
Click to expand...

Don't let FACTS get in your way SH_ _ for brains; Januvia was first synthesized and then developed by, Merck Research Labs. IF you worked for Merck, you'd know that.
 




Anonymous said:
Your moron is in your bathroom mirror every morning. Januvia was licensed. Merck just brought it to market. The OP asked for a home-grown product. Januvia isn't one.
Click to expand...

Januvia is licensed? From where? The last top selling product for us that is licensed is Cozaar and Hyzaar from DuPont and there was a JV called DuPont Merck. Singulair is home grown. Pepcid was licensed from Yammanouchi. All of our ophthalmic products are home grown. So are our vaccines. Prilosec was licensed from Astra 20+ years ago and there was also a JV called Astra Merck. Vasotec and Prinivil are home grown. Zocor and Mevacor are home grown. Zetia and Vytorin were a result of the Merck/SP JV. Vioxx was made at Merck too, and same for Indocin, Dolobid, and Clinoril. Would you be kind enough to share info about where did Merck sign the licensing agreement regarding Januvia?
 




hi all. OP here.

I think Sitigliptan was developed in house. And I do consider it a success. So that makes one successful in-house product in the last decade to get to market, find success and stay successful. Of course, I think a better DPP4 inhibitor is just around the corner...

At any rate, Merck is indeed dead. I remember the Merck that was thriving and it's completely gone. I would say it's flat-out dead. Sorry. I miss it, too.
 




Anonymous said:
Don't let FACTS get in your way SH_ _ for brains; Januvia was first synthesized and then developed by, Merck Research Labs. IF you worked for Merck, you'd know that.
Click to expand...

There are a lot of reps with very little tenure that speak like they know Merck. I used to have to listen to them doing those grand talks. A good quiz for them would be the meaning of the brand name, "Dolobid". If they can answer it then they pass. If not, then they belong to the crop of Barbies and Kens.
 




Anonymous said:
Januvia is licensed? From where? The last top selling product for us that is licensed is Cozaar and Hyzaar from DuPont and there was a JV called DuPont Merck. Singulair is home grown. Pepcid was licensed from Yammanouchi. All of our ophthalmic products are home grown. So are our vaccines. Prilosec was licensed from Astra 20+ years ago and there was also a JV called Astra Merck. Vasotec and Prinivil are home grown. Zocor and Mevacor are home grown. Zetia and Vytorin were a result of the Merck/SP JV. Vioxx was made at Merck too, and same for Indocin, Dolobid, and Clinoril. Would you be kind enough to share info about where did Merck sign the licensing agreement regarding Januvia?
Click to expand...

Your post reads like a history post. It's an illustration of what this company once was. The vaccines are struggling and Singulair is on the verge of patent loss. Aside form those, it's all ancient history.

And did you really mean to mention Zetia and Vytorin? Their sales have been great...for two of the crappiest products in pharmaceutical history. They are perfect examples of what Merck has become---all glitz and no substance.

Hey, maybe we should add Zocor to Januvia and call that a new product, too! That's a great idea. This company is an embarrassment. It's failure is forthcoming. And deservedly so.
 




you people are dumb shits, Merck is a 112B dollar company. It ain't goin no where. Your job may be going but it isn't. I work for Merck and love my job, I work hard, help pateients, get paid for it and help the company. I am no pill pusher, I work with the docs to treat patients and they love me for it. I am a resource, you are not it sounds like. When lipitor goes off, we will be #1. for what ever that is worth. I feel your pain, this company is way too big and steps all over its self trying to help the patient and the docs. Treat it like its your own company in your territory and forget about all the other stuff happening around you that they think is important. You get paid once a year so relax and do your job, they couldn't fire your for the numbers because they don't even know what they are. They don't fire on numbers anyway, look at all the people you know that got let go in the past and tell me it was on numbers. Ride this wave while you can, you could be working 9 to 5. We are not. And its a great life.
 




Anonymous said:
you people are dumb shits, Merck is a 112B dollar company. It ain't goin no where. Your job may be going but it isn't. I work for Merck and love my job, I work hard, help pateients, get paid for it and help the company. I am no pill pusher, I work with the docs to treat patients and they love me for it. I am a resource, you are not it sounds like. When lipitor goes off, we will be #1. for what ever that is worth. I feel your pain, this company is way too big and steps all over its self trying to help the patient and the docs. Treat it like its your own company in your territory and forget about all the other stuff happening around you that they think is important. You get paid once a year so relax and do your job, they couldn't fire your for the numbers because they don't even know what they are. They don't fire on numbers anyway, look at all the people you know that got let go in the past and tell me it was on numbers. Ride this wave while you can, you could be working 9 to 5. We are not. And its a great life.
Click to expand...

From where I'm sitting, you look like one of the people who realizes what a joke his career actually is, but you're getting paid enough to accept it. I am one of those who had a little more dignity than to continue to act like a fraud. That's not really a criticism; it's just a difference between two people. What's right for isn't right for me. Good luck to you.
 
















Anonymous said:
you people are dumb shits, Merck is a 112B dollar company. It ain't goin no where. Your job may be going but it isn't. I work for Merck and love my job, I work hard, help pateients, get paid for it and help the company. I am no pill pusher, I work with the docs to treat patients and they love me for it. I am a resource, you are not it sounds like. When lipitor goes off, we will be #1. for what ever that is worth. I feel your pain, this company is way too big and steps all over its self trying to help the patient and the docs. Treat it like its your own company in your territory and forget about all the other stuff happening around you that they think is important. You get paid once a year so relax and do your job, they couldn't fire your for the numbers because they don't even know what they are. They don't fire on numbers anyway, look at all the people you know that got let go in the past and tell me it was on numbers. Ride this wave while you can, you could be working 9 to 5. We are not. And its a great life.
Click to expand...

You probably at least try to be a resource, I can give you that. But I'm afraid in the end, like it or not, you're still a pull pusher of one variety or another. The statement about Merck stepping all over itself is very true but I have to take issue that it is done in trying to help the patient and docs. That seems way too pollyanna-ish for me. It is done because Merck suffers from lousy incompetent self-centered management that cares only about themselves and holding on to their piece of the pie. That simple.
 




Top Bottom
Back
Quote